HY-100131-10mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-100mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-2mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-5mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-50mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100183-10mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
HY-100183-100mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
HY-100183-25mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
HY-100183-5mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
HY-100183-50mg
|
MedChemexpress LLC
|
GSK2239633A [CAS 1240516-71-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-10mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-100mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-25mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-5mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100223-50mg
|
MedChemexpress LLC
|
Calpeptin [CAS 117591-20-5]
|
|
COVID-19-immunoregulation
|
|
HY-100269-1mg
|
MedChemexpress LLC
|
Chymase-IN-1 [CAS 862090-74-2]
|
|
COVID-19-immunoregulation
|
|
HY-100302-1mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-10mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-100mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-25mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-5mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-100302-50mg
|
MedChemexpress LLC
|
FR183998 free base [CAS 239440-20-1]
|
|
COVID-19-immunoregulation
|
|
HY-10037-10mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-100mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
HY-10037-5mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|